Final answer:
For NSTEMI patients, both statins and beta-blockers have been shown to reduce mortality by managing cholesterol and heart rate, respectively.
Step-by-step explanation:
In patients experiencing a Non-ST-segment Elevation Myocardial Infarction (NSTEMI), certain medications have been shown to reduce mortality. Statins are known to reduce cholesterol and lower the risk of coronary artery disease. Beta-blockers work by blocking beta-1 receptors, which slows the heart rate and can be beneficial in the treatment of hypertension; they have also revolutionized the treatment of cardiac patients. Antiplatelet drugs such as aspirin are crucial for breaking up clots that can cause further ischemia. Calcium channel blockers can be used to manage blood pressure and chest pain associated with NSTEMI, but they are not primarily used for reducing mortality in these patients. Therefore, options A) Statins and B) Beta-blockers have been demonstrated to reduce mortality in NSTEMI patients.